Art
J-GLOBAL ID:202202276490328273   Reference number:22A1167776

Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer

がんの基礎研究,診断,治療におけるCRISPR/Cas9ベース遺伝子編集技術の応用【JST・京大機械翻訳】
Author (19):
Material:
Volume: 20  Issue:Page: 1-22  Publication year: 2021 
JST Material Number: U7336A  ISSN: 1476-4598  Document type: Article
Article type: 文献レビュー  Country of issue: United Kingdom (GBR)  Language: ENGLISH (EN)
Abstract/Point:
Abstract/Point
Japanese summary of the article(about several hundred characters).
All summary is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
The 2020 Nobel Prize in Chemis...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=22A1167776&from=J-GLOBAL&jstjournalNo=U7336A") }}
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
, 【Automatic Indexing@JST】
JST classification (1):
JST classification
Category name(code) classified by JST.
Gene manipulation 
Reference (200):
  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209-49.
  • Lancet Oncol; Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial; R Stupp, ME Hegi, WP Mason, MJ Bent, MJ Taphoorn, RC Janzer; 10; 2009; 459-466; 10.1016/S1470-2045(09)70025-7; citation_id=CR2
  • Cell.; Lessons from the cancer genome; LA Garraway, ES Lander; 153; 2013; 17-37; 10.1016/j.cell.2013.03.002; citation_id=CR3
  • Nat Rev Cancer; Applications of the CRISPR-Cas9 system in cancer biology; FJ Sánchez-Rivera, T Jacks; 15; 2015; 387-395; 10.1038/nrc3950; citation_id=CR4
  • Annu Rev Pathol; Driver and passenger mutations in cancer; JR Pon, MA Marra; 10; 2015; 25-50; 10.1146/annurev-pathol-012414-040312; citation_id=CR5
more...

Return to Previous Page